340B Drug Pricing Program Policy Papers Patient Medical Debt: Findings from Quantitative Surveying of Patients in the United States (April 2025)En españolIs the 340B Drug Pricing Program the Next 'Too Big to Fail'? (March 2025)En españolThe 340B Drug Pricing Program and its Potential Impacts on Annual Revenues, Executive Compensation, and Charity Care Provision in Eligible Covered Entities – Supplemental Report (February 2025)En españolThe 340B Drug Pricing Program and its Potential Impacts on Annual Revenues, Executive Compensation, and Charity Care Provision in Eligible Covered Entities (July 2024)En español
